Indonesia vs Philippines: Access to anti-retroviral drugs, male
Indonesia
44.0%
in 2024
Philippines
42.0%
in 2024
Indonesia rank
126th
Philippines rank
128th
Access to anti-retroviral drugs, male over time
- Indonesia
- Philippines
How they compare
Indonesia currently reports 44.0% against 42.0% in Philippines, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Philippines ahead.
Indonesia ranks 126th and Philippines ranks 128th of 141 countries.
Philippines has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 1.3% | 0.2% | Philippines |
| 2010s | 11.2% | 21.5% | 10.3% | Philippines |
| 2020s | 31.8% | 41.4% | 9.6% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Indonesia or Philippines?
- Indonesia, at 44.0% against 42.0% in Philippines as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Indonesia and Philippines?
- 2.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Philippines?
- 25 years are reported by both, from 2000 to 2024.
- How do Indonesia and Philippines rank globally for access to anti-retroviral drugs, male?
- Indonesia ranks 126th and Philippines ranks 128th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.